[Leish-l] VL in elderly_Italy

Farrokh Modabber fmodabber at dndi.org
Fri Apr 13 14:28:27 BRT 2012


Dear Luigi, dear All,
Thanks Luigi.  Why then we insist on calling the causative agent L. infantum.
Personally I prefer L. chagasi.
Sorry, I don't seem to be able to use italics in this message for the organisms.
Best regards,
Farrokh

-----Original Message-----
From: leish-l-bounces at lineu.icb.usp.br [mailto:leish-l-bounces at lineu.icb.usp.br] On Behalf Of Luigi Gradoni
Sent: vendredi 13 avril 2012 00:51
To: tropmed-l-bounces at lineu.icb.usp.br; leish-l at lineu.icb.usp.br
Subject: [Leish-l] VL in elderly_Italy

Dears,
here in Italy we have great experience in treating elderly patients for VL. I agree that Ambisome is the best (only) choice, administered with precautions of monitoring lab parameters.
For those who are interested in age-related leishmaniasis in Italy, please find attached a graph showing some 1300 VL cases reported by age group who were diagnosed in my lab at Istituto Superiore di Sanità, Rome (www.iss.it) and treated with L-AmB in different hospitals. Those
40 patients above 70 years old included several cases in the 90-99 yrs age subgroup, who were all treated successfully.
The attached data are unpublished, so please treat them for information exchange only.

Best

Luigi Gradoni

Head, Section of Vector-borne Diseases & International health Istituto Superiore di Sanità, Rome



At 22.13 12/04/2012, tropmed-l-bounces at lineu.icb.usp.br wrote:
>Return-Path: <torduna at intramed.net>
>X-Original-To: tropmed-L at lineu.icb.usp.br
>Delivered-To: tropmed-L at lineu.icb.usp.br
>Received: from barracuda.icb.usp.br 
>(chagas.icb.usp.br [143.107.123.10])        by
>  lineu.icb.usp.br (Postfix) with ESMTP id 1EF8E2ADEA    for
>  <tropmed-L at lineu.icb.usp.br>; Tue, 10 Apr 2012 22:39:24 -0300 (BRT)
>X-ASG-Debug-ID: 1334108372-02c9651e4b10de90001-aJp0sq
>Received: from va3outboundpool.messaging.microsoft.com
>  (va3ehsobe006.messaging.microsoft.com [216.32.180.16]) by
>  barracuda.icb.usp.br with ESMTP id 8VZJ6Dw224z5rDPH for
>  <tropmed-L at lineu.icb.usp.br>; Tue, 10 Apr 2012 22:39:33 -0300 (BRT)
>X-Barracuda-Envelope-From: torduna at intramed.net
>X-Barracuda-Apparent-Source-IP: 216.32.180.16
>Received: from mail6-va3-R.bigfish.com (10.7.14.239) by
>  VA3EHSOBE001.bigfish.com (10.7.40.21) with Microsoft SMTP Server id
>  14.1.225.23; Wed, 11 Apr 2012 01:39:10 +0000
>Received: from mail6-va3 (localhost 
>[127.0.0.1])        by mail6-va3-R.bigfish.com
>  (Postfix) with ESMTP id 5BED7240081;   Wed, 11 Apr 2012 01:39:10 +0000 (UTC)
>X-Barracuda-RBL-IP: 10.7.40.21
>X-SpamScore: 4
>X-BigFish: PS4(zzc89bhc85dhbf2Izz1202hzz8275chz2fh2a8h668h839hd25h307m)
>X-Forefront-Antispam-Report: 
>CIP:207.46.4.203;KIP:(null);UIP:(null);IPV:NLI;H:SN2PRD0102HT015.prod.e
>xchangelabs.com;RD:none;EFVD:NLI
>Received-SPF: pass (mail6-va3: domain of intramed.net designates 
>207.46.4.203 as permitted sender) client-ip=207.46.4.203; 
>envelope-from=torduna at intramed.net;
>helo=SN2PRD0102HT015.prod.exchangelabs.com ;angelabs.com ;
>Received: from mail6-va3 (localhost.localdomain [127.0.0.1]) by 
>mail6-va3
>  (MessageSwitch) id 1334108347686481_22799; Wed, 11 Apr 2012 01:39:07 
>+0000
>  (UTC)
>Received: from VA3EHSMHS015.bigfish.com (unknown [10.7.14.248]) by
>  mail6-va3.bigfish.com (Postfix) with ESMTP id 
> 99CD92004E;      Wed, 11 Apr 2012
>  01:39:07 +0000 (UTC)
>Received: from SN2PRD0102HT015.prod.exchangelabs.com (207.46.4.203) by
>  VA3EHSMHS015.bigfish.com (10.7.99.25) with Microsoft SMTP Server 
>(TLS) id
>  14.1.225.23; Wed, 11 Apr 2012 01:39:07 +0000
>Received: from SN2PRD0102MB156.prod.exchangelabs.com ([169.254.9.128]) 
>by
>  SN2PRD0102HT015.prod.exchangelabs.com ([10.27.50.109]) with mapi id
>  14.15.0057.001; Wed, 11 Apr 2012 01:39:06 +0000
>From: Tomas Agustin Orduna <torduna at intramed.net>
>To: Kleber Luz <klebergluz at gmail.com>, "tropmed-L at lineu.icb.usp.br"
>         <tropmed-L at lineu.icb.usp.br>
>Subject: RE: [Tropmed-l] LV patiente 92y old
>Thread-Topic: [Tropmed-l] LV patiente 92y old
>X-ASG-Orig-Subj: RE: [Tropmed-l] LV patiente 92y old
>Thread-Index: AQHNF1flpZY6bT8OikuHBfKcSwzfEZaU1MC/
>Date: Wed, 11 Apr 2012 01:39:05 +0000
>Message-ID: 
><CAB4862254D15843823601155FDBBDCA1785A9B9 at SN2PRD0102MB156.prod.exchange
>labs.com>
>References: 
><CAGnGMp3OkR-F0Q9yYjGn-xK8BbMO3aGoG_3gW6YFoG2-z+sgMw at mail.gmail.com>
>In-Reply-To: 
><CAGnGMp3OkR-F0Q9yYjGn-xK8BbMO3aGoG_3gW6YFoG2-z+sgMw at mail.gmail.com>
>Accept-Language: es-AR, pt-BR, en-US
>Content-Language: es-AR
>X-MS-Has-Attach:
>X-MS-TNEF-Correlator:
>x-originating-ip: [10.27.90.255]
>Content-Type: multipart/alternative;
> 
>boundary="_000_CAB4862254D15843823601155FDBBDCA1785A9B9SN2PRD0102MB156_"
>X-OriginatorOrg: intramed.net
>X-Barracuda-Connect: 
>va3ehsobe006.messaging.microsoft.com[216.32.180.16]
>X-Barracuda-Start-Time: 1334108373
>X-Barracuda-URL: http://143.107.123.10:8000/cgi-mod/mark.cgi
>X-Virus-Scanned: by bsmtpd at icb.usp.br
>X-Barracuda-Bayes: INNOCENT GLOBAL 0.3223 1.0000 -0.2564
>X-Barracuda-Spam-Score: -0.26
>X-Barracuda-Spam-Status: No, SCORE=-0.26 using global scores of 
>TAG_LEVEL=4.0
>QUARANTINE_LEVEL=1000.0 KILL_LEVEL=4.5 tests=HTML_MESSAGE
>X-Barracuda-Spam-Report: Code version 3.2, rules version 3.2.2.93764
>         Rule breakdown below
>         pts rule name              description
>         ---- ----------------------
> --------------------------------------------------
>         0.00 HTML_MESSAGE           BODY: HTML included in message
>MIME-Version: 1.0
>
>Hello Giovanni: My experience with LV is at the moment very little, but 
>I am thinking about the treatment to him. I think it is important not 
>to put at risk with some risky drugs this old patient and try to be 
>very cautious. I prefer Anfo liposomal with a close control of 
>laboratory parameters (specially renal funtion)
>
>Please tell us about the outcome !
>
>Best regards
>
>
>
>Dr. Tomás A. Orduna
>Jefe de Servicio
>Patologías Regionales y Medicina Tropical (CEMPRA-MT) Hospital de 
>Infecciosas F. J. Muñiz Uspallata 2272 (C.P. 1282) Buenos Aires - 
>Argentina
>T.E.:(54-11) 4305-3161
>T.E.:Conmutador:(+54-11) 4305-0357/1944(int.231)
>Fax: (+54-11) 4304-2386
><mailto:torduna at intramed.net>torduna at intramed.net
>
>
>
>PS: In 1997 I had the great opportunity to know your hopsital and to 
>learn about dengue with Dra Ana Maria Acevedo before we have the first 
>outbreak in Argentina. I remember that time with an special acknowledgment.
>
>
>
>
>
>----------
>De: tropmed-l-bounces at lineu.icb.usp.br 
>[tropmed-l-bounces at lineu.icb.usp.br] en nombre 
>de Kleber Luz [klebergluz at gmail.com]
>Enviado el: lunes, 09 de abril de 2012 22:11
>Para: tropmed-L at lineu.icb.usp.br
>Asunto: [Tropmed-l] LV patiente 92y old
>
>Hello every body! Today i had done a diagnose of 
>VL in a patient 92 y old, test fast test was 
>positive and the bone marrow aspireted was 
>positive with a lot of leishmanias. Does anyone 
>had a patient like this. He was HIV negative.
>
>--
>Prof.Adjunto III -  Kleber Giovanni Luz - 
>DEPARTAMENTO DE INFECTOLOGIA/UFRN/HOSPITAL GISELDA TRIGUEIRO
>Rua Cônego Monte, 110 - QUINTAS
>CEP 59037-170
>NATAL-RN
>FONE (FAX): (84) - 3215-1603
>FONE: (84) - 3232-7948
>CEL: (84) - 9193 - 6208
>
>
>_______________________________________________
>Leish-l mailing list
>Leish-l at lineu.icb.usp.br
>http://lineu.icb.usp.br/cgi-bin/mailman/listinfo/leish-l

===================================================================================
L'Istituto Superiore di Sanità (ISS) è tra i beneficiari dei proventi del 5 per mille dell'IRPEF.
Nella scheda allegata alla dichiarazione dei redditi è sufficiente apporre la propria firma nel riquadro "Finanziamento della Ricerca Sanitaria" e indicare il Codice Fiscale dell'ISS, che è 80211730587, per destinare tali fondi a sostegno dell'impegno scientifico dell'ISS a difesa della salute di tutti.
===================================================================================




More information about the Leish-l mailing list